{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:02:17Z","timestamp":1781143337957,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900229"],"award-info":[{"award-number":["81900229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.numecd.2026.104701","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:48:24Z","timestamp":1773474504000},"page":"104701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SGLT2 inhibition, high-density lipoprotein cholesterol and aortic aneurysm: A drug-target Mendelian randomization study"],"prefix":"10.1016","volume":"36","author":[{"given":"Zheng-Qi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Zhen","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Ke","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Xiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2954-6190","authenticated-orcid":false,"given":"Yi-He","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.numecd.2026.104701_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41569-018-0114-9","article-title":"Abdominal aortic aneurysm: update on pathogenesis and medical treatments","volume":"16","author":"Golledge","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.numecd.2026.104701_bib2","article-title":"Surgery for small asymptomatic abdominal aortic aneurysms","volume":"7","author":"Ulug","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.numecd.2026.104701_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12933-025-02600-3","article-title":"The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus","volume":"24","author":"Zheng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2026.104701_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117236","article-title":"SGLT2-inhibition increases total, LDL, and HDL cholesterol and lowers triglycerides: meta-analyses of 60 randomized trials, overall and by dose, ethnicity, and drug type","volume":"394","author":"Bechmann","year":"2024","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamacardio.2017.4293","article-title":"Genetic association of lipids and lipid drug targets with abdominal aortic aneurysm: a meta-analysis","volume":"3","author":"Harrison","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2026.104701_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003898","article-title":"The evolution of mendelian randomization for investigating drug effects","volume":"19","author":"Gill","year":"2022","journal-title":"PLoS Med"},{"issue":"47","key":"10.1016\/j.numecd.2026.104701_bib8","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.numecd.2026.104701_bib9","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.numecd.2026.104701_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","article-title":"Computationally efficient whole-genome regression for quantitative and binary traits","volume":"53","author":"Mbatchou","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2026.104701_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105285","article-title":"Exploring antidiabetic drug targets as potential disease-modifying agents in osteoarthritis","volume":"107","author":"Fu","year":"2024","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.numecd.2026.104701_bib12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"7944","key":"10.1016\/j.numecd.2026.104701_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"7890","key":"10.1016\/j.numecd.2026.104701_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.numecd.2026.104701_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/1082-989X.7.1.83","article-title":"A comparison of methods to test mediation and other intervening variable effects","volume":"7","author":"MacKinnon","year":"2002","journal-title":"Psychol Methods"},{"issue":"2","key":"10.1016\/j.numecd.2026.104701_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.numecd.2026.104701_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"4","key":"10.1016\/j.numecd.2026.104701_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in Mendelian randomization studies","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"},{"issue":"5","key":"10.1016\/j.numecd.2026.104701_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.numecd.2026.104701_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"11","key":"10.1016\/j.numecd.2026.104701_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.numecd.2026.104701_bib23","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/ATVBAHA.119.312659","article-title":"SGLT-2 (Sodium-Glucose cotransporter 2) inhibition reduces Ang II (Angiotensin II)-induced dissecting abdominal aortic aneurysm in ApoE (Apolipoprotein E) knockout mice","volume":"39","author":"Ortega","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2026.104701_bib24","article-title":"Dapagliflozin ameliorates the formation and progression of experimental abdominal aortic aneurysms by reducing aortic inflammation in mice","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12933-017-0529-3","article-title":"Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial","volume":"16","author":"Fadini","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19371-6","article-title":"Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure","volume":"12","author":"Ejiri","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-019-0839-8","article-title":"How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial","volume":"18","author":"Bosch","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.numecd.2026.104701_bib28","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.dsx.2019.01.016","article-title":"Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center","volume":"13","author":"Calapkulu","year":"2019","journal-title":"Diabetes Metabol Syndr"},{"issue":"4","key":"10.1016\/j.numecd.2026.104701_bib29","first-page":"371","article-title":"Serum high-density and low-density lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis","volume":"29","author":"Takagi","year":"2010","journal-title":"Int Angiol"},{"issue":"4","key":"10.1016\/j.numecd.2026.104701_bib30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jvs.2024.12.004","article-title":"Association between high-density lipoprotein cholesterol and risk of abdominal aortic aneurysm among males and females aged 60 years and over","volume":"81","author":"Peng","year":"2025","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.numecd.2026.104701_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1160\/TH14-10-0874","article-title":"ApoA-I\/HDL-C levels are inversely associated with abdominal aortic aneurysm progression","volume":"113","author":"Burillo","year":"2015","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.numecd.2026.104701_bib32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2012.04.015","article-title":"Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model","volume":"181","author":"Krishna","year":"2012","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib33","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1096\/fj.201801245R","article-title":"Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy","volume":"33","author":"Keul","year":"2019","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.numecd.2026.104701_bib34","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/ATVBAHA.118.311704","article-title":"Impaired HDL (High-Density Lipoprotein)-Mediated macrophage cholesterol efflux in patients with abdominal aortic aneurysm-brief report","volume":"38","author":"Martinez-Lopez","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.numecd.2026.104701_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/vhrm.1.2.119.64083","article-title":"Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium","volume":"1","author":"Norata","year":"2005","journal-title":"Vasc Health Risk Manag"},{"issue":"13","key":"10.1016\/j.numecd.2026.104701_bib36","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/cvr\/cvy174","article-title":"Diabetes and aortic aneurysm: current state of the art","volume":"114","author":"Raffort","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.numecd.2026.104701_bib37","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1038\/s41467-024-49921-7","article-title":"Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation","volume":"15","author":"Zheng","year":"2024","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.numecd.2026.104701_bib38","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.numecd.2026.104701_bib39","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/dom.14816","article-title":"Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: the randomized, open-label, crossover, active-comparator FIORE trial","volume":"24","author":"Succurro","year":"2022","journal-title":"Diabetes Obes Metabol"},{"issue":"9","key":"10.1016\/j.numecd.2026.104701_bib40","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326001638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326001638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:45:39Z","timestamp":1781142339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326001638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0939475326001638"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104701","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibition, high-density lipoprotein cholesterol and aortic aneurysm: A drug-target Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104701"}}